Over the past 4 decades, thyroid cancer incidence rates have increased nearly 3-fold,
1,2 resulting in its current status as one of the most commonly diagnosed cancers in the US. During the 1990s, thyroid cancer incidence rates began to increase from an annual age-standardized rate of 4.9 to 14.2 per 100 000 person-years in 2010-2014.
1 Rates among US men (8.0 per 100 000 person-years) are about one-third that of women (23.3 per 100 000 person-years), although mortality rates are similar, at 0.52 vs 0.49 per 100 000 person-years.
1 The increased incidence is primarily limited to the least aggressive histologic type: papillary thyroid cancer.
2-6